Heska

Heska EBITDA

Delisted

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Heska (HSKA) as of Nov 1, 2026 is -21.22 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -993,000.00 USD — a change of 2,037.06% (lower).

EBITDA

-21.22 MUSD

YoY

2,037.06%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Heska is 2022 -21.22 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Heska was 2021 -993,000.00 USD. It decreases by 2,037.06% lower compared to the previous year.

The Heska EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2015
8.56 M USD
Jan 1, 2016
16.53 M USD
Jan 1, 2017
18.30 M USD
Jan 1, 2018
-801,000.00 USD
Jan 1, 2019
-4.59 M USD
Jan 1, 2020
-8.19 M USD
Jan 1, 2021
-993,000.00 USD
Jan 1, 2022
-21.22 M USD
The Heska EBITDA history
YEAREBITDAYoY
-21.22 MUSD+2,037.06%
-993,000.00USD-87.88%
-8.19 MUSD+78.51%
-4.59 MUSD+472.91%
-801,000.00USD-104.38%
18.30 MUSD+10.67%
16.53 MUSD+93.21%
8.56 MUSD+193.95%
2.91 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Heska Stock analysis

What does Heska do? Heska Corp was founded in 2001 and has since become a leading company in the field of animal health. The company is headquartered in Loveland, Colorado and has locations in the USA, Europe, and Asia. Heska's business model is based on the development, manufacturing, and marketing of innovative diagnostic and therapeutic products for animals. The company aims to provide veterinarians and pet owners with a comprehensive range of solutions to support the health and well-being of animals. Heska has divided itself into three main divisions in order to cover the entire spectrum of animal health: diagnosis, therapy, and traceability. In the "diagnosis" division, Heska offers a wide range of diagnostic test kits for various animals, including dogs, cats, horses, cattle, and pigs. The tests include blood tests, urine tests, imaging tests, and molecular diagnostics. Heska's therapy division includes products for the treatment of animals, including medications, vaccines, and pet conditioners. The company also develops innovative therapy approaches to combat diseases in animals, including oncology. Another important aspect of Heska's business model is offering targeted solutions for seamless traceability of animals for agricultural and veterinary purposes. The company offers a wide selection of animal identification products that are known for their reliability and safety. Heska is committed to continuously improving and innovating its products to help animals and pet owners worldwide. The company aims to achieve better access to healthcare for animals through its research and development in the field of animal health, thus improving the lives of all animals. In summary, Heska Corp is a significant company in the field of animal health that specializes in the development and marketing of diagnostic and therapeutic products for animals. The company's products are valued by veterinarians and pet owners worldwide and contribute to improving the health and well-being of animals. Heska is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Heska stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Heska is -21.22 M USD in 2022.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Heska changed from -993,000.00 USD to -21.22 M USD, representing a 2,037.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Heska since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Heska historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Heska

All Key Metrics — Heska